Overview Dividends

(MOH) Molina Healthcare - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US60855R1005

Medicaid, Medicare, Health Insurance, Managed Care

MOH EPS (Earnings per Share)

EPS Growth (3Y CAGR): 8.67%
EPS Trend (3Y Correlation): 55.9%

MOH Revenue

Revenue Growth (3Y CAGR): 14.22%
Revenue Trend (3Y Correlation): 98.2%

Description: MOH Molina Healthcare

Molina Healthcare Inc (NYSE:MOH) is a managed healthcare services provider catering to low-income families and individuals through Medicaid and Medicare programs, as well as state insurance marketplaces. With operations across 21 states, the company has established a significant presence in the US healthcare landscape.

The companys diversified business segments, including Medicaid, Medicare, Marketplace, and Other, enable it to navigate the complexities of the US healthcare system. As a managed care organization, Molina Healthcares revenue is largely driven by premium payments from government programs and insurance marketplaces. Key performance indicators (KPIs) to watch include membership growth, revenue per member per month (PMPM), and medical loss ratio (MLR), which can impact the companys profitability.

From a financial perspective, Molina Healthcares market capitalization stands at approximately $9.9 billion, with a forward price-to-earnings (P/E) ratio of 8.27, indicating a relatively attractive valuation compared to its earnings. The companys return on equity (RoE) of 25.54% suggests strong profitability. Other important metrics to monitor include the companys debt-to-equity ratio, operating cash flow, and administrative expense ratio, which can provide insights into its financial health and operational efficiency.

To further evaluate Molina Healthcares investment potential, its essential to analyze its competitive positioning within the managed care industry, its ability to navigate regulatory changes, and its growth prospects in the Medicaid and Medicare markets. A thorough examination of these factors can help investors make informed decisions about the companys stock.

MOH Stock Overview

Market Cap in USD	9,804m
Sub-Industry	Managed Health Care
IPO / Inception	2003-07-02

MOH Stock Ratings

Growth Rating	-50.9%
Fundamental	79.4%
Dividend Rating	-
Return 12m vs S&P 500	-57.9%
Analyst Rating	3.75 of 5

MOH Dividends

Currently no dividends paid

MOH Growth Ratios

Growth Correlation 3m	-53.4%
Growth Correlation 12m	-58.9%
Growth Correlation 5y	41.5%
CAGR 5y	-19.17%
CAGR/Max DD 3y	-0.30
CAGR/Mean DD 3y	-0.98
Sharpe Ratio 12m	-0.64
Alpha	0.01
Beta	0.985
Volatility	55.80%
Current Volume	980.8k
Average Volume 20d	1295.9k
Stop Loss	168 (-4.7%)
Signal	0.03

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (1.13b TTM) > 0 and > 6% of Revenue (6% = 2.60b TTM)

FCFTA 0.03 (>2.0%) and ΔFCFTA 1.46pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 12.06% (prev 12.02%; Δ 0.04pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.03 (>3.0%) and CFO 537.0m <= Net Income 1.13b (YES >=105%, WARN >=100%)

Net Debt (-936.0m) to EBITDA (1.85b) ratio: -0.50 <= 3.0 (WARN <= 3.5)

Current Ratio 1.66 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (54.3m) change vs 12m ago -6.70% (target <= -2.0% for YES)

Gross Margin 10.94% (prev 12.14%; Δ -1.20pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 276.6% (prev 246.3%; Δ 30.23pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 10.73 (EBITDA TTM 1.85b / Interest Expense TTM 154.0m) >= 6 (WARN >= 3)

Altman Z'' 4.04

(A) 0.32 = (Total Current Assets 13.11b - Total Current Liabilities 7.88b) / Total Assets 16.21b

(B) 0.26 = Retained Earnings (Balance) 4.16b / Total Assets 16.21b

(D) 0.36 = Book Value of Equity 4.15b / Total Liabilities 11.61b

Total Rating: 4.04 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 79.41

1. Piotroski 6.0pt = 1.0

2. FCF Yield 4.92% = 2.46

3. FCF Margin 0.98% = 0.25

4. Debt/Equity 0.73 = 2.24

5. Debt/Ebitda 1.82 = 0.35

6. ROIC - WACC (= 8.71)% = 10.88

7. RoE 24.86% = 2.07

8. Rev. Trend 98.23% = 7.37

9. EPS Trend 55.89% = 2.79

What is the price of MOH shares?

As of September 18, 2025, the stock is trading at USD 176.32 with a total of 980,800 shares traded.
Over the past week, the price has changed by -1.58%, over one month by +4.24%, over three months by -39.70% and over the past year by -50.06%.

Is Molina Healthcare a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Molina Healthcare (NYSE:MOH) is currently (September 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 79.41 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MOH is around 123.16 USD . This means that MOH is currently overvalued and has a potential downside of -30.15%.

Is MOH a buy, sell or hold?

Molina Healthcare has received a consensus analysts rating of 3.75. Therefor, it is recommend to hold MOH.

Strong Buy: 6
Buy: 1
Hold: 8
Sell: 1
Strong Sell: 0

What are the forecasts/targets for the MOH price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	196.7	11.6%
Analysts Target Price	196.7	11.6%
ValueRay Target Price	136	-22.9%

Last update: 2025-09-15 04:40

MOH Fundamental Data Overview

Market Cap USD = 9.80b (9.80b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 4.50b USD (last quarter)
P/E Trailing = 8.9191
P/E Forward = 9.0171
P/S = 0.2351
P/B = 2.1298
P/EG = -0.62
Beta = 0.54
Revenue TTM = 43.41b USD
EBIT TTM = 1.65b USD
EBITDA TTM = 1.85b USD
Long Term Debt = 3.38b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (0.0)
Debt = 3.38b USD (Calculated: Short Term 0.0 + Long Term 3.38b)
Net Debt = -936.0m USD (from netDebt column, last quarter)
Enterprise Value = 8.68b USD (9.80b + Debt 3.38b - CCE 4.50b)
Interest Coverage Ratio = 10.73 (Ebit TTM 1.65b / Interest Expense TTM 154.0m)
FCF Yield = 4.92% (FCF TTM 427.0m / Enterprise Value 8.68b)
FCF Margin = 0.98% (FCF TTM 427.0m / Revenue TTM 43.41b)
Net Margin = 2.60% (Net Income TTM 1.13b / Revenue TTM 43.41b)
Gross Margin = 10.94% ((Revenue TTM 43.41b - Cost of Revenue TTM 38.66b) / Revenue TTM)
Tobins Q-Ratio = 2.09 (Enterprise Value 8.68b / Book Value Of Equity 4.15b)
Interest Expense / Debt = 1.42% (Interest Expense 48.0m / Debt 3.38b)
Taxrate = 25.80% (410.0m / 1.59b)
NOPAT = 1.23b (EBIT 1.65b * (1 - 25.80%))
Current Ratio = 1.66 (Total Current Assets 13.11b / Total Current Liabilities 7.88b)
Debt / Equity = 0.73 (Debt 3.38b / last Quarter total Stockholder Equity 4.60b)
Debt / EBITDA = 1.82 (Net Debt -936.0m / EBITDA 1.85b)
Debt / FCF = 7.90 (Debt 3.38b / FCF TTM 427.0m)
Total Stockholder Equity = 4.54b (last 4 quarters mean)
RoA = 6.97% (Net Income 1.13b, Total Assets 16.21b )
RoE = 24.86% (Net Income TTM 1.13b / Total Stockholder Equity 4.54b)
RoCE = 20.87% (Ebit 1.65b / (Equity 4.54b + L.T.Debt 3.38b))
RoIC = 16.15% (NOPAT 1.23b / Invested Capital 7.60b)
WACC = 7.44% (E(9.80b)/V(13.18b) * Re(9.64%)) + (D(3.38b)/V(13.18b) * Rd(1.42%) * (1-Tc(0.26)))
Shares Correlation 3-Years: -33.85 | Cagr: -0.53%
Discount Rate = 9.64% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 64.73% ; FCFE base≈327.8m ; Y1≈225.0m ; Y5≈112.5m
Fair Price DCF = 31.39 (DCF Value 1.70b / Shares Outstanding 54.2m; 5y FCF grow -36.71% → 3.0% )
EPS Correlation: 55.89 | EPS CAGR: 8.67% | SUE: -0.12 | # QB: 0
Revenue Correlation: 98.23 | Revenue CAGR: 14.22% | SUE: N/A | # QB: None

Additional Sources for MOH Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle